FAKTOR OPTIONSSCHEIN - MEDTRONIC Share Price

Certificat

DE000PN2MED2

Market Closed - Deutsche Boerse AG 20:50:23 28/06/2024 BST
11.05 EUR -0.27% Intraday chart for FAKTOR OPTIONSSCHEIN - MEDTRONIC
Current month-4.08%
1 month-6.59%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
28/06/24 11.05 -0.27%
27/06/24 11.08 -2.03%
26/06/24 11.31 +0.09%
25/06/24 11.3 -2.16%
24/06/24 11.55 -1.70%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 08:50 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN2MED
ISINDE000PN2MED2
Date issued 09/11/2021
Strike 79.33 $
Maturity Unlimited
Parity 1 : 1
Emission price 30
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 30.26
Lowest since issue 8.8
Spread 0.11
Spread %0.98%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
78.71 USD
Average target price
94.02 USD
Spread / Average Target
+19.46%
Consensus